Abstract
“Click” reactions have transformed the molecular sciences. Augmenting cycloaddition reactions, sulfur(VI) fluoride exchange (SuFEx) chemistry has diversified the landscape of molecular assembly. Herein, we report a facile strategy to access SuFExable NH-pyrazoles via strain and catalyst-free 1,3-dipolar cycloadditions of stabilized diazo compounds under mild conditions. Subsequent SuFEx proceeds efficiently with various N- and O-nucleophiles. Access to SuFExable NH-pyrazoles—a class of compounds containing two common pharmacophores—enables future opportunities within drug discovery, chemical biology, materials chemistry, and related fields.
Graphical Abstract

Modularity has overwhelmed modern chemical synthesis, enabling innovative strategies within chemical biology, materials chemistry, and other disciplines within the molecular sciences. This molecular revolution has been “defined, enabled, and constrained by a handful of nearly perfect “spring-loaded” reactions”.1
The race to disclose “perfect” chemical strategies was inspired by nature’s use of a core set of building blocks and reactions. Attractive features of pericyclic reactions, and the discovery of the copper-catalyzed azide–alkyne cycloaddition (CuAAC),2 have endowed 1,3-dipolar cycloadditions as the prototype (Scheme 1A).3 The extension to chemical biology necessitated the removal of the Cu catalysts. To meet this requirement, the strain-promoted azide–alkyne cycloaddition (SPAAC),4,5 tetrazine–trans-cylooctene inverse-demand Diels–Alder,6 and related reactions7 were developed and optimized.8,9 In parallel, applications enabled by modularity flourished.10
Scheme 1. Exemplary Click Reactionsa.

a(A) The 1,3-dipolar cycloaddition between an azide and an alkyne. (B) Commonly employed sulfur(VI) fluoride exchange (SuFEx) reactions. (C) Sulfonyl fluoride-containing dipolarophiles.
As the number of available reactions expands, the utility of each depends on access to reagents, reaction conditions, and efficiency, among other criteria. While the “click” strategy focuses on the modular assembly of building blocks, the properties of generated linkages is of growing interest.1
Sulfur(VI) fluoride exchange (SuFEx) has recently been endowed a “click” reaction (Scheme 1B).11 The increased stability of sulfonyl fluorides over sulfonyl chlorides and favorable attributes of the sulfonyl group enable unique opportunities.12,13 The utility of SuFEx stems from latent reactivity that can be exploited for late-stage diversification,14 the prevalence of sulfonyl linkages in drug compounds,15 and other attractive features.16
Among methods to generate SuFEx “hubs”, various 1,3-dipoles have been reported to undergo cycloadditions with ethenylsulfonyl fluoride (ESF),17 1-bromoethene-1-sulfonyl fluoride (Br-ESF),18 substituted alkynylsulfonyl fluorides (SASFs),19 and other dipoles (Scheme 1C).20 While these reactions furnish diverse heterocyclic scaffolds able to undergo subsequent SuFEx chemistry, the requisite conditions (i.e., catalyst, base, heat, etc.) limit their utility.
We report within that the reactivity inherent to diazo compounds21 enables access to sulfonyl fluoride-substituted pyrazoles and pyrazolines under mild conditions via 1,3-dipolar cycloaddition with Br-ESF or ESF, respectively (Figure 1A).17b,22 Computational analysis reveals that this dipole–dipolarophile pair is well-matched to harness stereoelectronic transition-state stabilization.8f-i,21d-g,23 Subsequent SuFEx reactions of the obtained NH-pyrazoles enable rapid access to diverse scaffolds containing two clinically important pharmacophores (Figure 1B).15,24 Facile transformation of azides—ubiquitous within the “click” realm—into diazo compounds renders this strategy advantageous for the generation of SuFEx “hubs” utilizing readily available starting materials.
Figure 1.
Pyrazolyl SuFEx hubs enable access to medicinally important molecular scaffolds. (A) Ambient temperature, catalyst-free 1,3-dipolar cycloadditions of diazo compounds with ESF and Br-ESF afford pyrazolines 3 and pyrazoles 4, respectively. (B) Biologically active compounds containing both a pyrazole heterocycle and a sulfonyl fluoride or sulfonamide.
We first sought to confirm the utility of ethenylsulfonyl fluorides as dipolarophiles in reactions with stabilized diazo compounds under mild conditions. Both ESF and Br-ESF undergo rapid 1,3-dipolar cycloadditions with N-benzyldiazoa-cetamide 1a and ethyl diazoacetate 1b, yielding the pyrazoline 3 and pyrazole 4 cycloadducts, respectively (Figure 1A). Regioselectivity was determined utilizing J-coupling values (2JHH, 3JHH, 4JHF) from 1H NMR spectroscopy and (2JCF) from 13C NMR spectroscopy. The latter enables additional structural data afforded by heteronuclear single quantum coherence (see the Supporting Information). As expected, the nucleophilic character inherent to diazo compounds enforces high regioselectivity with the “perfect” Michael acceptor,25 providing 3,5-disubstituted pyrazoles and pyrazolines.21b,26
Notably, organic azides do not react with ESF or Br-ESF under these conditions (7 h; room temperature) and require heating, as was previously reported.17,18 This chemoselective reactivity of diazo compounds enables cycloadditions in the presence of the azido group, broadening the scope and diversity of potential substrates for this reaction.10c,d,21c-e
To understand the increased reactivity of diazo compounds over azides in the reaction with ESF and Br-ESF, we performed quantum chemical calculations. We optimized starting materials and transition states and examined frontier molecular orbital energies (Figure 2A,B). The higher-energy HOMO of ethyl diazoacetate 1b, relative to ethyl azidoacetate 2b, facilitates the normal-demand (type I) 1,3-dipolar cyclo-additions. The matched FMOs of 1b and Br-ESF result in lower free energies of activation relative to the reaction of 2b, in agreement with the distortion/interaction analysis (see Table S1).26b,27
Figure 2.
Diazo compounds provide a distinct advantage in the generation of heterocyclic SuFEx hubs. (A) Matched frontier molecular orbital energies facilitate the diazo–Br-ESF cycloaddition. (B) Transition-state geometries optimized at the M06-2X/6-311++G(d,p) level of theory. NBO charges (italics) indicate the degree of charge transfer in the TS. (C) Depiction of stabilizing orbital interactions in the 1b–Br-ESF TS: alignment of the S─F antibonding orbital (σ*SF) with the Br-ESF π-system facilitates bond formation.
We performed natural bonding orbital (NBO) analysis28 to reveal specific interactions responsible for the increased reactivity of diazo compounds with ethenylsulfonyl fluorides. Charge transfer from the 1,3-dipole to ESF was quantified by examining the NBO charges on each species in the TS (Figure 2B).21e In agreement with FMO energies, increased charge transfer is observed in the 1b–Br-ESF TS, where the dominant interaction is from the HOMO of 1b to the LUMO of ESF. Stabilization to the TS is provided by the sulfonyl fluoride. Directional charge transfer results in a partially filled π*CC, which is delocalized into the S─F bond antibonding orbital (σ*SF; Figure 2C). This π*CC → σ*SF interaction facilitates bond formation. Analogous interactions with C─X bonds (X = O, N, S) provide both an effective strategy to accelerate 1,3-dipolar cycloadditions of cyclic alkynes8f-i,21d-g,23 and the stereoelectronic basis for the Felkin–Anh model of asymmetric induction.29 Reaction development for the assembly of SuFEx hubs18-20 can be accelerated by harnessing this design principle.
The favorable electronics of the diazo group, the pyrazole products obtained, and the mild reaction conditions—which enable diazo-selective reactivity in the presence of azides—render the reported 1,3-dipolar cycloadditions an attractive route to pyrazolyl SuFEx hubs for broad applications. Moreover, the brightly colored solutions of diazo compounds 1a and 1b rapidly decolorize upon the addition of Br-ESF, providing a colorimetric indicator of reaction progress. Still, to solidify a place within the “click” arsenal, these pyrazolyl sulfonyl fluorides must also display efficient SuFEx reactivity. To demonstrate the scope and diversity of this modular scaffold for molecular assembly, we next examined conditions to determine general protocols for SuFEx with both nitrogen- and oxygen-based nucleophiles (Table 1).
Table 1.
Optimization of SuFEx Reaction Conditions with Primary Amines, Aryl Alcohols, and Silyl Ethers
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| entry | nucleophile | equiv | base | equiv | additive | equiv | time, h | T, °C | yield, %a |
| 1 | BnNH2 | 2 | — | — | — | — | 24 | r.t. | — |
| 2 | BnNH2 | 2 | — | — | — | — | 24 | 80 | — |
| 3 | BnNH2 | 2 | DIPEA | 2 | — | — | 72 | r.t. | 19 |
| 4 | BnNH2 | 2 | DIPEA | 2 | — | — | 24 | 80 | 50 |
| 5 | BnNH2 | 1.1 | DABCO | 2.1 | — | — | 18 | r.t. | 29 |
| 6 | BnNH2 | 1.1 | DABCO | 2.1 | Ca(NTf2) | 1.4 | 2 | r.t. | 94 |
| 7 | 3,4-diMe-PhO-TMS | 1.1 | DABCO | 2.1 | Ca(NTf2) | 1.4 | 48 | r.t. | >99 |
| 8 | 3,4-diMe-PhOH | 1.1 | DABCO | 3.1 | Ca(NTf2) | 1.4 | 18 | r.t. | 93 |
| 9 | 3,4-diMe-PhO-TMS | 1.1 | DBU | 3 | — | — | 48 | 80 | 77 |
Determined by HPLC.
We first attempted the reaction of 4a with benzylamine (2 equiv) in acetonitrile; however, no reaction was observed via HPLC after 24 h at room temperature or at reflux (entries 1 and 2, respectively). The use of DIPEA (2 equiv) was found to facilitate the reaction, albeit sluggishly, as only 19% conversion was observed after 72 h (entry 3). Heating to 80 °C was moderately beneficial, resulting in 50% conversion after 24 h (entry 4).
A promising result was obtained upon substituting DIPEA with DABCO, where 29% conversion was observed after only 18 h at room temperature (entry 5). Further optimization gave a 94% yield of the desired sulfonamide 6d within 2 h at room temperature (entry 6). This result was achieved by slight modifications to protocols developed by the Ball group30—benzylamine (1.1 equiv) with a combination of DABCO (2.1 equiv) and calcium bistriflimide (1.4 equiv) to activate the sulfonyl fluoride.
Analogous reactions of aryl silyl ethers proceeded smoothly, though noticeably slower. The room-temperature reaction of 4a with 3,4-xylenyl trimethylsilyl ether in the presence of DABCO (2.1 equiv) and Ca(NTf2)2 (1.4 equiv) gave a quantitative yield of sulfonate 5a within 48 h (entry 7). Interestingly, reactions proceeded equally well utilizing the unprotected 3,4-xylenol and were completed within 18 h. In addition to Ca(NTf2)2 (1.4 equiv), an extra equivalent of DABCO was required (entry 8).31 Alternately, DBU can be used without addition of Ca(NTf2)2 in reactions of aryl silyl ethers within the same timespan. However, this method requires elevated temperatures (80 °C) and furnished 5a in decreased yield (entry 9).
We next examined the scope of nucleophiles compatible with these pyrazolyl SuFEx hubs (Scheme 2). Employing optimized conditions (entries 6 and 8), we synthesized pyrazolyl sulfonates 5 and pyrazolyl sulfonamides 6. Aryl alcohols bearing both electron-donating and electron-with-drawing substituents gave the corresponding pyrazolyl sulfonates 5a–e in 77–92% yields. Benzyl and phenylamine afforded the corresponding sulfonamides in >81% yield (6a,c,d), while the morpholine yielded 6b in 74%. Overall, these newly reported pyrazolyl SuFEx hubs react quite efficiently.
Scheme 2.
Synthesis of Pyrazolyl Sulfonates and Pyrazolyl Sulfonamides via SuFEx Reactions Illustrating the Scope of Reported Pyrazolyl SuFEx Hubs
We envisioned that—in addition to selective 1,3-dipolar cycloaddition reactions (i.e., diazo compounds over azides; vide supra)—selective SuFEx reactivity will enable multistage diversification strategies. We examined the fluoride exchange reaction of 4a with excess benzyl amine (2 equiv) and 3,4-xylenol (2 equiv), both in the presence and absence of Lewis acid (Ca(NTf2)2) (Scheme 3A). We found near perfect chemoselectivity favoring the sulfonamide 6d over 5c (95:1) in the absence of Lewis acid. As expected, activating the electrophile decreased the selectivity to 3:1, still favoring 6d. This differentiation between nucleophiles can be exploited for chemoselective SuFEx reactivity.
Scheme 3.
(A) Amine-Selective SuFEx Reaction in the Presence of Aryl Alcohol and (B) Base-Promoted Formation of Monosubstituted NH-Pyrazoles via −SO2F Elimination from Pyrazoline 3a
Monosubstituted NH-pyrazole 7a was generated from pyrazoline 3a (Scheme 3B). Analogous aromatization was previously observed in reactions of azides.17a The mild reaction conditions (i.e., ambient temperatures) enable isolation of pyrazoline product 3a, whereas the azido cycloadduct spontaneously aromatized via loss of SO2 and HF in previous reports. While attempts at SuFEx with N- and O-nucleophiles (with and without base) triggered pyrazole formation, this mild synthesis of monosubstituted NH-pyrazoles avoids the use of harsh reagents (e.g., hydrazine) and/or conditions and metal catalysts that are commonly employed. We are currently exploring the utility of on-demand base-triggered aromatization, which simultaneously generates a fluoride ion while planarizing a tetrahedral carbon atom.
In conclusion, NH-pyrazole sulfonyl fluorides (SuFEX hubs) were generated via 1,3-dipolar cycloadditions of 1-bromoe-thene-1-sulfonyl fluoride (Br-ESF) with stabilized diazoacetamides and diazoacetates—electronically matched 1,3-dipoles—under ambient conditions. Subsequent sulfur(VI) fluoride exchange was optimized for both nitrogen- and oxygen-based nucleophiles, affording sulfonamides and sulfonates, respectively. Selectivity was observed at each step in the reported “double-click” strategy, enabling future design of “click hubs” containing both a sulfonyl fluoride and an azido group. Overall, facile generation of starting materials from readily available precursors,32 distinct advantages of diazo compounds21 (and the resulting NH-pyrazole),33 and highly selective reactivity enable myriad opportunities for multistage diversification strategies that remain true to the “click” mantra.
Supplementary Material
ACKNOWLEDGMENTS
This work was supported by a Pilot Project Grant from the University of New Mexico Center of Metals in Biology and Medicine under grant number P20 GM130422 (NIH) and an Institutional Development Award (IDeA) under grant number P20 GM103451 (NIH). M.A.M.F. was supported, in part, by a Ph.D. Scholarship from the Central Luzon State University Faculty Development Program. High-performance calculations made use of resources at the UNM Center for Research Computing, which is supported in part by the National Science Foundation. Work was performed at the University of New Mexico, which lies on the traditional homelands of the Pueblo of Sandia; for more information, see https://diverse.unm.edu/about/land-acknowledgement.html.
Footnotes
Supporting Information
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.joc.1c03105.
Synthetic methods and analytical data, along with computational methods and data, Cartesian coordinates, energies, and imaginary frequencies (for TSs) of optimized structures (PDF)
The authors declare the following competing financial interest(s): University of New Mexico has applied for a patent on technology described in this Note.
Contributor Information
Pavel Yamanushkin, Department of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico 87131, United States.
Kemal Kaya, Department of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico 87131, United States; Department of Biochemistry, Kutahya Dumlupinar University, 43100 Kutahya, Turkey.
Mark Aldren M. Feliciano, Department of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico 87131, United States.
Brian Gold, Department of Chemistry and Chemical Biology, University of New Mexico, Albuquerque, New Mexico 87131, United States.
REFERENCES
- (1).Kolb HC; Finn MG; Sharpless KB Angew. Chem, Int. Ed 2001, 40, 2004–2021. [DOI] [PubMed] [Google Scholar]
- (2).Rostovtsev VV; Green LG; Fokin VV; Sharpless KB Angew. Chem, Int. Ed.2002, 41, 2596–2599. [DOI] [PubMed] [Google Scholar]
- (3).(a) Huisgen R Angew. Chem., Int. Ed 1963, 2, 565–598. [Google Scholar]; (b) Breugst M; Reissig H-U Angew. Chem., Int. Ed 2020, 59, 12293–12307. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (4).(a) Blomquist AT; Liu LH J. Am. Chem. Soc 1953, 75, 2153–2154. [Google Scholar]; (b) Wittig G; Krebs A Chem. Ber 1961, 94, 3260–3275. [Google Scholar]; (c) Banert K; Köhler F Angew. Chem., Int. Ed 2001, 40, 174–177. [DOI] [PubMed] [Google Scholar]
- (5).Agard NJ; Prescher JA; Bertozzi CR J. Am. Chem. Soc 2004, 126, 15046–15047. [DOI] [PubMed] [Google Scholar]
- (6).Blackman ML; Royzen M; Fox JM J. Am. Chem. Soc 2008, 130, 13518–13519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (7).Hoyle CE; Bowman CN Angew. Chem., Int. Ed 2010, 49, 1540–1573. [DOI] [PubMed] [Google Scholar]
- (8).(a) Baskin JM; Prescher JA; Laughlin ST; Agard NJ; Chang PV; Miller IA; Lo A; Codelli JA; Bertozzi CR Proc. Natl. Acad. Sci. U.S.A 2007, 104, 16793–16797. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Ning X; Guo J; Wolfert MA; Boons G-J Angew. Chem., Int. Ed 2008, 47, 2253–2255. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Debets MF; van Berkel SS; Schoffelen S; Rutjes FPJT; van Hest JCM; van Delft FL Chem. Commun 2010, 46, 97–99. [DOI] [PubMed] [Google Scholar]; (d) Kuzmin A; Poloukhtine A; Wolfert MA; Popik VV Bioconjugate Chem. 2010, 21, 2076–2085. [DOI] [PubMed] [Google Scholar]; (e) Dommerholt J; Schmidt S; Temming R; Hendriks LJA; Rutjes FPJT; van Hest JCM; Lefeber DJ; Friedl P; van Delft FL Angew. Chem., Int. Ed 2010, 49, 9422–9425. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Burke EG; Gold B; Hoang TT; Raines RT; Schomaker JM J. Am. Chem. Soc 2017, 139, 8029–8037. [DOI] [PMC free article] [PubMed] [Google Scholar]; (g) Hu Y; Roberts JM; Kilgore HR; Mat Lani AS; Raines RT ; Schomaker JM J. Am. Chem. Soc 2020, 142, 18826–18835. [DOI] [PMC free article] [PubMed] [Google Scholar]; (h) Dones JM; Abularrage NS; Khanal N; Gold B; Raines RT J. Am. Chem. Soc 2021, 143, 9489–9497. [DOI] [PMC free article] [PubMed] [Google Scholar]; (i) Danilkina NA; Govdi AI; Khlebnikov AF; Tikhomirov AO; Sharoyko VV; Shtyrov AA; Ryazantsev MN; Brase S; Balova IA J. Am. Chem. Soc 2021, 143, 16519. [DOI] [PubMed] [Google Scholar]
- (9).(a) Dommerholt J; Rutjes FPJT; van Delft FL Top. Curr. Chem 2016, 374, 16. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Harris T; Alabugin IV Mendeleev Commun. 2019, 29, 237–248. [Google Scholar]
- (10).(a) Sletten EM; Bertozzi CR Angew. Chem., Int. Ed 2009, 48, 6974–6998. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Patterson DM; Nazarova LA; Prescher JA ACS Chem. Biol 2014, 9, 592–605. [DOI] [PubMed] [Google Scholar]; (c) Nguyen SS; Prescher JA Nat. Rev. Chem 2020, 4, 476–489. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Hu Y; Schomaker JM ChemBioChem. 2021, 22, 3254. [DOI] [PubMed] [Google Scholar]; (e) Scinto SL; Bilodeau DA; Hincapie R; Lee W; Nguyen SS; Xu M; am Ende CW; Finn MG; Lang K; Lin Q; Pezacki JP; Prescher JA; Robillard MS; Fox JM Nat. Rev. Methods Primers 2021, 1, 30. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Devaraj NK; Finn MG Chem. Rev 2021, 121, 6697–6698. [DOI] [PubMed] [Google Scholar]
- (11).Dong J; Krasnova L; Finn MG; Sharpless KB Angew. Chem., Int. Ed 2014, 53, 9430–9448. [DOI] [PubMed] [Google Scholar]
- (12).(a) Gushwa NN; Kang S; Chen J; Taunton J J.Am. Chem. Soc 2012, 134, 20214–20217. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Fadeyi O; Parikh MD; Chen MZ; Kyne RE Jr.; Taylor AP; O’Doherty I; Kaiser SE; Barbas S; Niessen S; Shi M; Weinrich SL; Kath JC; Jones LH; Robinson RP ChemBioChem. 2016, 17, 1925–1930. [DOI] [PubMed] [Google Scholar]; (c) Chen W; Dong J; Plate L; Mortenson DE; Brighty GJ; Li S; Liu Y; Galmozzi A; Lee PS; Hulce JJ; Cravatt BF; Saez E; Powers ET; Wilson IA; Sharpless KB; Kelly JW J. Am. Chem. Soc. 2016, 138, 7353–7364. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Oakdale JS; Kwisnek L; Fokin VV Macromolecules 2016, 49, 4473–4479. [Google Scholar]; (e) Kitamura S; Zheng Q; Woehl JL; Solania A; Chen E; Dillon N; Hull MV; Kotaniguchi M; Cappiello JR; Kitamura S; Nizet V; Sharpless KB; Wolan DW J. Am. Chem. Soc 2020, 142, 10899–10904. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Zheng Q; Woehl JL; Kitamura S; Santos-Martins D; Smedley CJ; Li G; Forli S; Moses JE; Wolan DW; Sharpless KB Proc. Natl. Acad. Sci. U.S.A 2019, 116, 18808–18814. [DOI] [PMC free article] [PubMed] [Google Scholar]; (g) Nie X; Xu T; Hong Y; Zhang H; Mao C; Liao S Angew. Chem., Int. Ed 2021, 60, 22035–22042. [DOI] [PubMed] [Google Scholar]; (h) Li S; Wu P; Moses JE; Sharpless KB Angew. Chem., Int. Ed 2017, 56, 2903–2908. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (13).(a) Barrow AS; Smedley CJ; Zheng Q; Li S; Dong J; Moses JE Chem. Soc. Rev 2019, 48, 4731–4758. [DOI] [PubMed] [Google Scholar]; (b) Lee C; Cook AJ; Elisabeth JE; Friede NC; Sammis GM; Ball ND ACS Catal. 2021, 11, 6578–6589. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Geng Z; Shin JJ; Xi Y; Hawker CJ J. Polym. Sci 2021, 59, 963–1042. [Google Scholar]
- (14).Liu Z; Li J; Li S; Li G; Sharpless KB; Wu P J. Am. Chem. Soc 2018, 140, 2919–2925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (15).(a) Francisco KR; Varricchio C; Paniak TJ; Kozlowski MC; Brancale A; Ballatore C Eur. J. Med. Chem 2021, 218, 113399. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Zhao C; Rakesh KP; Ravidar L; Fang W-Y; Qin H-L Eur. J. Med. Chem 2019, 162, 679–734. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (16).(a) Narayanan A; Jones LH Chem. Sci 2015, 6, 2650–2659. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Mortenson DE; Brighty GJ; Plate L; Bare G; Chen W; Li S; Wang H; Cravatt BF; Forli S; Powers ET; Sharpless KB; Wilson IA; Kelly JW J. Am. Chem. Soc 2018, 140, 200–210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (17).(a) Giel M-C; Smedley CJ; Mackie ERR; Guo T; Dong J; Soares da Costa TP; Moses JE Angew. Chem., Int. Ed 2020, 59, 1181–1186. [DOI] [PubMed] [Google Scholar]; (b) Jangra H; Chen Q; Fuks E; Zenz I; Mayer P; Ofial AR; Zipse H; Mayr H J. Am. Chem. Soc 2018, 140, 16758–16772. [DOI] [PubMed] [Google Scholar]
- (18).(a) Thomas J; Fokin VV Org. Lett 2018, 20, 3749–3752. [DOI] [PubMed] [Google Scholar]; (b) Smedley CJ; Giel M-C; Molino A; Barrow AS; Wilson DJD; Moses JE Chem. Commun 2018, 54, 6020–6023. [DOI] [PubMed] [Google Scholar]; (c) Leng J; Qin H-L Chem. Commun 2018, 54, 4477–4480. [DOI] [PubMed] [Google Scholar]; (d) Eremin DB; Fokin VV J. Am. Chem. Soc 2021, 143, 18374–18379. [DOI] [PubMed] [Google Scholar]
- (19).Smedley CJ; Li G; Barrow AS; Gialelis TL; Giel M-C; Ottonello A; Cheng Y; Kitamura S; Wolan DW; Sharpless KB; Moses JE Angew. Chem., Int. Ed 2020, 59, 12460–12469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (20).(a) Fang W-Y; Wang S-M; Zhang Z-W; Qin H-L Org. Lett 2020, 22, 8904–8909. [DOI] [PubMed] [Google Scholar]; For early reports of ESF and halo-ESF chemistry, see: (b) Hedrick RM U.S. Patent US2653973, 1953. [Google Scholar]; (c) Truce WE; Hoerger FD J. Am. Chem. Soc 1954, 76, 3230. [Google Scholar]; (d) Gladshtein BM; Chernetskii VN; Kiseleva MI; Soborovskii LZ J. Gen. Chem. USSR (Engl. Transl.) 1958, 28, 2145. [Google Scholar]; (e) Gladshtein BM; Polyanskaya EI; Soborovskii LZ J. Gen. Chem. USSR (Engl. Transl.) 1961, 31, 787. [Google Scholar]; (f) Krutak JJ; Burpitt RD; Moore WH; Hyatt JA J. Org. Chem 1979, 44, 3847–3858. [Google Scholar]; (g) Champseix A; Chanet J; Etienne A; Le Berre A; Lemasson J Napierala C; Vessiere R Bull. Soc. Chim. Fr 1985, 463–472. [Google Scholar]
- (21).(a) Mix KA; Aronoff MR; Raines RT ACS Chem. Biol 2016, 11, 3233–3244. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Bihlmaier W; Huisgen R; Reissig H-U; Vass S Tetrahedron Lett. 1979, 20, 2621–2624. [Google Scholar]; (c) Andersen KA; Aronoff MR; McGrath NA; Raines RT J. Am. Chem. Soc 2015, 137, 2412–2415. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Aronoff MR; Gold B; Raines RT Org. Lett 2016, 18, 1538–1541. [DOI] [PMC free article] [PubMed] [Google Scholar]; (e) Gold B; Aronoff MR; Raines RT J. Org. Chem 2016, 81, 5998–6006. [DOI] [PMC free article] [PubMed] [Google Scholar]; (f) Gold B; Aronoff MR; Raines RT Org. Lett 2016, 18, 4466–4469. [DOI] [PMC free article] [PubMed] [Google Scholar]; (g) Aronoff MR; Gold B; Raines RT Tetrahedron Lett. 2016, 57, 2347–2350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (22). Mykhailiuk PK Chem. Eur. J 2014, 20, 4942–4947. Slobodyanyuk EY; Artamonov OS; Shishkin OV; Mykhailiuk PK Eur. J. Org. Chem 2014, 2014, 2487–2495. N-substituted pyrazoles have been reported via the reactions of substituted alkynylsulfonyl fluorides (SASFs) with hydrazonoyl chloride and base or with sydnones at 120 °C; see reference 19.
- (23).(a) Gold B; Shevchenko NE; Bonus N; Dudley GB; Alabugin IV J. Org. Chem 2012, 77, 75–89. [DOI] [PubMed] [Google Scholar]; (b) Gold B; Dudley GB; Alabugin IV J. Am. Chem. Soc 2013, 135, 1558–1569. [DOI] [PubMed] [Google Scholar]; (c) Gold B; Batsomboon P; Dudley GB; Alabugin IV J. Org. Chem 2014, 79, 6221–6232. [DOI] [PubMed] [Google Scholar]
- (24).(a) Mykhailiuk PK Chem. Rev 2021, 121, 1670–1715. [DOI] [PubMed] [Google Scholar]; (b) Di Fruscia P; Carbone A; Bottegoni G; Berti F; Giacomina F; Ponzano S; Pagliuca C; Fiasella A; Pizzirani D; Ortega JA; Nuzzi A; Tarozzo G; Mengatto L; Giampa R; Penna I; Russo D; Romeo E; Summa M; Bertorelli R; Armirotti A; Bertozzi SM; Reggiani A; Bandiera T; Bertozzi F J.Med. Chem 2021, 64, 13327–13355. [DOI] [PMC free article] [PubMed] [Google Scholar]; (c) Zhao Q; Ouyang X; Wan X; Gajiwala KS; Kath JC; Jones LH; Burlingame AL; Taunton J J.Am. Chem. Soc 2017, 139, 680–685. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (25).Chen Q; Mayer P; Mayr H Angew. Chem., Int. Ed 2016, 55, 12664–12667. [DOI] [PubMed] [Google Scholar]
- (26).(a) Houk KN; Sims J; Duke RE; Strozier RW; George JK J. Am. Chem. Soc 1973, 95, 7287–7301. [Google Scholar]; (b) Ess DH; Houk KN J. Am. Chem. Soc 2008, 130, 10187–10198. [DOI] [PubMed] [Google Scholar]
- (27).Bickelhaupt FM; Houk KN Angew. Chem., Int. Ed 2017, 56, 10070–10086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (28).Glendening ED; Badenhoop JK; Reed AE; Carpenter JE;Bohmann JA; Morales CM; Karafiloglou P; Landis CR; Weinhold F NBO 7.0; Theoretical Chemistry Institute, University of Wisconsin–Madison: Madison, WI, 2018. [Google Scholar]
- (29).(a) Gung BW Chem. Rev 1999, 99, 1377–1386. [DOI] [PubMed] [Google Scholar]; (b) Nguyen Trong A; Eisenstein O; Lefour JM; Tran Huu Dau ME J. Am. Chem. Soc 1973, 95, 6146–6147. [Google Scholar]; (c) Chérest M; Felkin H; Prudent N Tetrahedron Lett. 1968, 9, 2199–2204. [Google Scholar]; (d) Chérest M; Felkin H Tetrahedron Lett. 1971, 12, 383–386. [Google Scholar]
- (30).Mahapatra S; Woroch CP; Butler TW; Carneiro SN; Kwan SC; Khasnavis SR; Gu J; Dutra JK; Vetelino BC; Bellenger J; Am Ende CW; Ball ND Org. Lett 2020, 22, 4389–4394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (31).Liang DD; Streefkerk DE; Jordaan D; Wagemakers J; Baggerman J; Zuilhof H Angew. Chem., Int. Ed 2020, 59, 7494. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (32).(a) Myers EL; Raines RT Angew. Chem., Int. Ed 2009, 48, 2359–2363. [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Lu G-H; Huang T-C; Hsueh H-C; Yang S-C; Cho T-W; Chou H-H Chem. Commun 2021, 57, 4839–4842. [DOI] [PubMed] [Google Scholar]; (c) Chou H-H; Raines RT J. Am. Chem. Soc 2013, 135, 14936–14939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (33).Chen S-J; Golden DL; Krska SW; Stahl SS J. Am. Chem. Soc 2021, 143, 14438–14444. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




